Myeloproliferative Neoplasms (MPN)

Health-related quality of life and symptom profile of patients with BCR::ABL1-negative myeloproliferative neoplasms: Real-world evidence from the GIMEMA-PROPHECY observational study

Original Publication Date
Article Source
External Web Content

Abstract Health-related quality of life (HRQoL) of patients with myeloproliferative neoplasms (MPNs) may be impaired across several domains. In this multicenter observational study, we evaluated HRQoL and symptoms in a cohort of MPN patients with validated measures, including the…

Rusfertide Continues to Show Strong Results for Polycythemia Vera

Original Publication Date
Article Source
External Web Content

Rusfertide sustained hematocrit control and sharply reduced phlebotomy need through week 52 in PV, showing durable efficacy and a consistent safety profile. Treatment with the hepcidin mimetic rusfertide continued to demonstrate sustained hematocrit control below 45% and high…

Oral Decitabine/Cedazuridine Plus Venetoclax Yields 91% ORR in High-Risk MDS and CMML

Original Publication Date
Article Source
External Web Content

Key Takeaways The combination therapy achieved a 91% overall response rate, with 45% complete remission and 46% marrow complete remission rates. Median overall survival was 30 months, with 1- and 3-year survival rates of 68.8% and 40.7%, respectively. SHOW MORE Decitabine…

Understanding Clinical Trials

Fact Sheet - Understanding Clinical Trials

This guide provides information about clinical trials and gives you some things to consider when deciding whether to take part

Financial Resources

Fact Sheet - Financial Resources

A list of organizations & programs that may provide financial resources & other assistance

ASH 2020

Research Summary - ASH 2020

Bone Marrow Failure Disease Research Summaries for Patients from the 2020 American Hematology Society Annual Meeting

Subscribe to Myeloproliferative Neoplasms (MPN)

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.